rosiglitazone

Known as: Rosiglitazona, (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion, 5-((4-(2-methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate 
An agent belonging to the glitazone class of antidiabetic agents with antihyperglycemic and anti-inflammatory activities. In addition to its… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1979-2017
020040019792017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
In this systematic review we analyzed studies that assessed serum concentrations of lipopolysaccharide (LPS) and/or… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2016
Review
2016
Among the epidemics of modern time, type 2 diabetes mellitus (T2DM) is one of the main contributors to overall morbidity as well… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylurea, or both, for lowering blood… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
AIM To compare the effects of combining liraglutide (0.6, 1.2 or 1.8 mg/day) or rosiglitazone 4 mg/day (all n >or= 228) or… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Rosiglitazone is widely used to treat patients with type 2 diabetes mellitus, but its effect on cardiovascular… (More)
  • table 3
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND A recent meta-analysis raised concern regarding an increased risk of myocardial infarction and death from… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND The efficacy of thiazolidinediones, as compared with other oral glucose-lowering medications, in maintaining long-term… (More)
  • figure 1
  • table 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Rosiglitazone is a thiazolidinedione that reduces insulin resistance and might preserve insulin secretion. The aim of… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Markers of systemic inflammation (eg, C-reactive protein [CRP] and interleukin-6 [IL-6]) have been proposed to be… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
AMP-activated protein kinase (AMPK) is activated within the cell in response to multiple stresses that increase the intracellular… (More)
Is this relevant?